2C-E-FLY
2C-E-FLY is a synthetic psychedelic compound belonging to the 2C family of phenethylamines. It is a structural analog of 2C-E and is known for its potent psychoactive effects. The compound is characterized by the presence of a benzodifuran ring system, which is a distinguishing feature of the FLY series of psychedelics.
Chemical Structure and Properties[edit | edit source]
2C-E-FLY is chemically known as 2-(2,5-dimethoxy-4-ethylphenyl)-2,3-dihydro-1H-benzo[d]furan. The compound features a methoxy group at the 2 and 5 positions of the benzene ring, an ethyl group at the 4 position, and a dihydrobenzofuran ring system. This structure is similar to that of 2C-E, but with the addition of the furan ring, which is believed to influence its pharmacological properties.
Pharmacology[edit | edit source]
The pharmacological profile of 2C-E-FLY is not well-documented, but it is presumed to act as a serotonin receptor agonist, similar to other compounds in the 2C family. The compound is thought to primarily interact with the 5-HT2A receptor, which is associated with the psychedelic effects of these substances. Users report effects such as altered perception, visual hallucinations, and changes in thought processes.
Effects[edit | edit source]
The effects of 2C-E-FLY are reported to be similar to those of other psychedelic phenethylamines, with a duration of action typically lasting between 6 to 10 hours. Common effects include:
- Visual and auditory hallucinations
- Enhanced sensory perception
- Altered sense of time
- Euphoria
- Introspection
Legal Status[edit | edit source]
The legal status of 2C-E-FLY varies by country. In some jurisdictions, it may be classified as a controlled substance due to its structural similarity to other regulated psychedelics. Users should be aware of the legal implications of possessing or using this compound in their respective regions.
Safety and Toxicity[edit | edit source]
There is limited information available on the safety and toxicity of 2C-E-FLY. As with other research chemicals, the potential for adverse effects and long-term health consequences is not well understood. Users should exercise caution and consider the potential risks associated with the use of this substance.
See Also[edit | edit source]
References[edit | edit source]
External Links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD